BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totaling 1,791 shares, a decrease of 94.5% from the August 31st total of 32,491 shares. Based on an average trading volume of 235,000 shares, the short-interest ratio is currently 0.0 days.
BioPharma Credit Stock Performance
Shares of BOPCF stock remained flat at $0.93 during mid-day trading on Thursday. BioPharma Credit has a 52 week low of $0.85 and a 52 week high of $1.02. The stock’s fifty day moving average is $0.96 and its 200-day moving average is $0.95.
About BioPharma Credit
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Further Reading
- Five stocks we like better than BioPharma Credit
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
